Illinois Administrative Code (Last Updated: March 27, 2024) |
TITLE77. PUBLIC HEALTH |
PART840. HEALTH AND HAZARDOUS SUBSTANCES REGISTRY CODE |
SUBPARTC. ADVERSE PREGNANCY OUTCOMES REPORTING SYSTEM |
§840.200. Adverse Pregnancy Outcome
-
An adverse pregnancy outcome for an infant consists of one or more of the following case criterion:
a) A diagnosis of a birth defect, made prenatally or by two years of age;
b) A gestational age of less than 31 completed weeks (ICD-10-CM P07.21-P07.33);
c) A diagnosis of fetal alcohol syndrome (ICD-10-CM Q86.0);
d) A fetal or neonatal death;
e) Substance Use
1) Prenatal maternal, post-natal infant or post-natal maternal positive toxicology for any controlled substance (except drugs administered during labor and delivery);
2) a maternal admission to illicit drug use, or cannabis use during the pregnancy that led to the delivery of this infant; or
3) signs of drug toxicity or withdrawal; or
f) A diagnosis of one of the following conditions made prior to discharge from the newborn hospitalization:
1) Serious infections:
A) Prenatal exposure to syphilis (ICD-10-CM Z20.2) or a diagnosis of congenital syphilis (ICD-10-CM A50.01-A53.9);
B) Prenatal exposure to hepatitis B or hepatitis C (ICD-10-CM Z20.2) or a diagnosis of hepatitis B or hepatitis C (ICD-10-CM P35.3);
C) Prenatal exposure to chlamydia (ICD-10-CM Z20.2) or a diagnosis of a chlamydial infection ICD-10-CM A74.89, A74.9, or P23.1);
D) Prenatal exposure to herpes (ICD-10-CM Z20.2) or a diagnosis of congenital herpes (ICD-10-CM P35.2);
E) Group B streptococcus (ICD-10-CM J15.3 or P36.0);
F) Gonococcal conjunctivitis (neonatorum) (ICD-10-CM P39.1);
G) Congenital listeriosis (ICD-10-CM P37.2);
H) Congenital rubella (ICD-10-CM P35.0);
I) Congenital cytomegalovirus (ICD-10-CM P35.1);
J) Tetanus neonatorum (ICD-10-CM A33);
K) Septicemia of the newborn ICD-10-CM P36.0-P36.9);
L) Prenatal exposure to human immunodeficiency virus (ICD-10-CM Z20.6); or
M) Other congenital infections (ICD-10-CM P35.8, P35.9 or P37.0-P37.9).
2) Endocrine, metabolic or immune disorder:
A) Hypothyroidism (ICD-10-CM E03.0-E03.9);
B) Adrenogenital syndrome (ICD-10-CM E25.0-E25.9);
C) Inborn errors of metabolism (- ICD-10-CM E70.0-E79.9);
D) Cystic fibrosis (ICD-10-CM E84.0-E84.9); or
E) Immune deficiency disorder (ICD-10-CM D80.0-D81.9).
3) Blood disorder:
A) Leukemia (ICD-10-CM C91.0-C95.92);
B) Hereditary hemolytic anemias (ICD-10-CM D58.0-D58.9);
C) Constitutional aplastic anemia (ICD-10-CM D61.0-D61.09); or
D) Coagulation defects (ICD-10-CM D65-D68.9).
4) Other conditions:
A) Neurofibromatosis (ICD-10-CM Q85.0-Q85.9);
B) Cerebral lipidoses ICD-10-CM E75.4);
C) Retinopathy of prematurity (ICD-10-CM H35.1-H35.17);
D) Chorioretinitis (ICD-10-CM H30.00-H30.93);
E) Strabismus (ICD-10-CM H50.00-H50.9);
F) Endocardial fibroelastosis (ICD-10-CM I42.4);
G) Occlusion of cerebral arteries (ICD-10-CM I63.30-I63.59 or I66.0-I66.9);
H) Bronchopulmonary dysplasia (ICD-10-CM P27.1);
I) Intrauterine growth retardation ICD-10-CM P05.0-P05.9);
J) Intraventricular hemorrhage grade III (ICD-10-CM P52.21);
K) Intraventricular hemorrhage grade IV ICD-10-CM P52.22);
L) Seizures (ICD-10-CM P90);
M) Other conditions leading to more than 72 hours on a ventilator (ICD-10-CM Z99.11);
N) Conditions leading to extracorporeal membrane oxygenation (ECMO) (ICD-10-CM Z92.81)
O) Erb's Palsy (ICD-10-CM P14.0)
P) Hypoxic ischemic encephalopathy leading to cooling treatment (ICD-10-CM P91.63)
AGENCY NOTE: The products of induced abortions shall not be reported to APORS.
(Source: Amended at 46 Ill. Reg. 2971, effective February 1, 2022)